{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T02:15:45Z","timestamp":1775009745780,"version":"3.50.1"},"reference-count":109,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.ejpb.2022.04.009","type":"journal-article","created":{"date-parts":[[2022,4,27]],"date-time":"2022-04-27T21:30:38Z","timestamp":1651095038000},"page":"27-42","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["In situ gelling nanosuspension as an advanced platform for fluticasone propionate nasal delivery"],"prefix":"10.1016","volume":"175","author":[{"given":"Laura","family":"Ni\u017ei\u0107 Nodilo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mirna","family":"Perku\u0161i\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivo","family":"Ugrina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Drago","family":"\u0160poljari\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cvijeta","family":"Jakobu\u0161i\u0107 Brala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Amid\u017ei\u0107 Klari\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jasmina","family":"Lovri\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vesna","family":"Sar\u0161on","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ma\u0161a","family":"Safund\u017ei\u0107 Ku\u010duk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dijana","family":"Zadravec","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Livije","family":"Kalogjera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivan","family":"Pepi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anita","family":"Hafner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl. 29","key":"10.1016\/j.ejpb.2022.04.009_b0005","first-page":"1","article-title":"EPOS 2020","author":"Fokkens","year":"2020","journal-title":"Off. J. Eur. Int. Rhinol. Soc. Confederation European ORL-HNS"},{"key":"10.1016\/j.ejpb.2022.04.009_b0010","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.2147\/JAA.S321332","article-title":"Intranasal corticosteroids: Topical potency, systemic activity and therapeutic index","volume":"14","author":"Daley-Yates","year":"2021","journal-title":"J. Asthma Allergy"},{"key":"10.1016\/j.ejpb.2022.04.009_b0015","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.ijpharm.2019.04.015","article-title":"Innovative sprayable in situ gelling fluticasone suspension: Development and optimization of nasal deposition","volume":"563","author":"Ni\u017ei\u0107","year":"2019","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.ejpb.2022.04.009_b0020","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.drudis.2015.10.016","article-title":"Smart materials: in situ gel-forming systems for nasal delivery","volume":"21","author":"Karavasili","year":"2016","journal-title":"Drug Discovery Today"},{"issue":"7","key":"10.1016\/j.ejpb.2022.04.009_b0025","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1211\/0022357023691","article-title":"Nanosuspensions: a promising drug delivery strategy","volume":"56","author":"Patravale","year":"2004","journal-title":"J. Pharm. Pharmacol."},{"issue":"1","key":"10.1016\/j.ejpb.2022.04.009_b0030","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1208\/s12249-012-9896-y","article-title":"Nanosuspension based in situ gelling nasal spray of carvedilol: Development, in vitro and in vivo characterization","volume":"14","author":"Saindane","year":"2013","journal-title":"AAPS PharmSciTech."},{"key":"10.1016\/j.ejpb.2022.04.009_b0035","doi-asserted-by":"crossref","first-page":"119166","DOI":"10.1016\/j.ijpharm.2020.119166","article-title":"Nasal delivery of nanosuspension-based mucoadhesive formulation with improved bioavailability of loratadine: Preparation, characterization, and in vivo evaluation","volume":"579","author":"Alshweiat","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2022.04.009_b0040","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.ijbiomac.2014.03.022","article-title":"Donepezil nanosuspension intended for nose to brain targeting: In vitro and in vivo safety evaluation","volume":"67","author":"Bhavna","year":"2014","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ejpb.2022.04.009_b0045","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.colsurfb.2016.08.011","article-title":"Fabrication of an ionic-sensitive in situ gel loaded with resveratrol nanosuspensions intended for direct nose-to-brain delivery","volume":"147","author":"Hao","year":"2016","journal-title":"Colloids Surf., B"},{"key":"10.1016\/j.ejpb.2022.04.009_b0050","doi-asserted-by":"crossref","first-page":"10435","DOI":"10.2147\/IJN.S265659","article-title":"Nose-to-brain delivery by nanosuspensions-based in situ gel for breviscapine","volume":"15","author":"Chen","year":"2020","journal-title":"Int. J. Nanomed."},{"issue":"2","key":"10.1016\/j.ejpb.2022.04.009_b0055","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s40199-019-00281-4","article-title":"Intranasal Zotepine Nanosuspension: intended for improved brain distribution in rats","volume":"27","author":"Pailla","year":"2019","journal-title":"DARU, J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2022.04.009_b0060","doi-asserted-by":"crossref","first-page":"120728","DOI":"10.1016\/j.ijpharm.2021.120728","article-title":"Spray-dried mucoadhesive microparticles based on S-protected thiolated hydroxypropyl-\u03b2-cyclodextrin for budesonide nasal delivery","volume":"603","author":"Racaniello","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2022.04.009_b0065","doi-asserted-by":"crossref","first-page":"4063","DOI":"10.2147\/IJN.S313093","article-title":"Clinical, biochemical and molecular evaluations of ivermectin mucoadhesive nanosuspension nasal spray in reducing upper respiratory symptoms of mild covid-19","volume":"16","author":"Aref","year":"2021","journal-title":"Int. J. Nanomed."},{"issue":"3","key":"10.1016\/j.ejpb.2022.04.009_b0070","doi-asserted-by":"crossref","first-page":"457","DOI":"10.2298\/CICEQ140609001D","article-title":"Priprema nano-strukturiranog flutikazon-propionat nazalnog spreja sa pobolj\u0161anom stabilno\u0161\u0107u i uniformno\u0161\u0107u","volume":"21","author":"Dai","year":"2015","journal-title":"Chem. Ind. Chem. Eng. Quart."},{"issue":"1","key":"10.1016\/j.ejpb.2022.04.009_b0075","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s40136-012-0003-4","article-title":"Topical Drug Delivery for Chronic Rhinosinusitis","volume":"1","author":"Liang","year":"2013","journal-title":"Curr. Otorhinolaryngol. Rep."},{"issue":"5","key":"10.1016\/j.ejpb.2022.04.009_b0080","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1177\/0145561320961004","article-title":"Positional Installation of Intranasal Corticosteroids in the Treatment of Chronic Rhinosinusitis: A Systematic Review of the Literature","volume":"100","author":"Cummings","year":"2021","journal-title":"Ear Nose Throat J."},{"issue":"4","key":"10.1016\/j.ejpb.2022.04.009_b0085","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1046\/j.1365-2273.2001.00473.x","article-title":"The delivery of topical nasal sprays and drops to the middle meatus: A semiquantitative analysis","volume":"26","author":"Tsikoudas","year":"2001","journal-title":"Clin. Otolaryngol. Allied Sci."},{"issue":"1-2","key":"10.1016\/j.ejpb.2022.04.009_b0090","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.ijpharm.2015.11.047","article-title":"Simple low-cost miniaturization approach for pharmaceutical nanocrystals production","volume":"501","author":"Romero","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2022.04.009_b0095","article-title":"Analysis of Linear Viscoelasticity of a Crosslinking Polymer at the Gel Point Analysis of Linear Viscoelasticity of a Crosslinking Polymer at the","volume":"367","author":"Winter","year":"1986","journal-title":"Gel Point."},{"issue":"7","key":"10.1016\/j.ejpb.2022.04.009_b0100","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/jps.20090","article-title":"Evaluation of different parameters that affect droplet-size distribution from nasal sprays using the Malvern Spraytec\u00ae","volume":"93","author":"Dayal","year":"2004","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2022.04.009_b0105","doi-asserted-by":"crossref","unstructured":"K. Shrestha, J. van Strien, N. Singh, K. Inthavong, Primary break-up and atomization characteristics of a nasal spray, PLoS ONE [Internet]. 15(8 August 2020) (2020)1\u201316. Available from: http:\/\/dx.doi.org\/10.1371\/journal.pone.0236063.","DOI":"10.1371\/journal.pone.0236063"},{"issue":"3","key":"10.1016\/j.ejpb.2022.04.009_b0110","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1063\/1.555688","article-title":"International Tables of Water Surface Tension","volume":"12","author":"Vargaftik","year":"1983","journal-title":"J. Phys. Chem. Ref. Data"},{"issue":"1","key":"10.1016\/j.ejpb.2022.04.009_b0115","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.ijpharm.2018.06.058","article-title":"A modified USP induction port to characterize nasal spray plume geometry and predict turbinate deposition under flow","volume":"548","author":"Moraga-Espinoza","year":"2018","journal-title":"Int. J. Pharm."},{"issue":"1-2","key":"10.1016\/j.ejpb.2022.04.009_b0120","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.ijpharm.2014.10.044","article-title":"Effects of stabilizing agents on the development of myricetin nanosuspension and its characterization: An in vitro and in vivo evaluation","volume":"477","author":"Hong","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2022.04.009_b0125","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.carbpol.2018.07.054","article-title":"Box-Behnken design optimization of mucoadhesive chitosan-coated nanoemulsions for rosmarinic acid nasal delivery\u2014In vitro studies","volume":"199","author":"Fachel","year":"2018","journal-title":"Carbohydr. Polym."},{"issue":"6","key":"10.1016\/j.ejpb.2022.04.009_b0130","doi-asserted-by":"crossref","first-page":"795","DOI":"10.3390\/pharmaceutics13060795","article-title":"A dry powder platform for nose-to-brain delivery of dexamethasone: Formulation development and nasal deposition studies","volume":"13","author":"Ni\u017ei\u0107 Nodilo","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2022.04.009_b0135","unstructured":"Ph. Eur. Commission. European Pharmacopoeia (Ph. Eur.) 10th Edition [Internet]. 2021 [cited 2021 Dec 1]. Available from: https:\/\/www.edqm.eu\/en\/european-pharmacopoeia-ph-eur-10th-edition."},{"key":"10.1016\/j.ejpb.2022.04.009_b0140","unstructured":"European Medicines Agency London UK. European Medicines Agency. Validation of Analytical Procedures: Text and Methodology Q2(R1) [Internet]. 2005. Available from: https:\/\/database.ich.org\/sites\/default\/files\/Q2%28R1%29Guideline.pdf."},{"key":"10.1016\/j.ejpb.2022.04.009_b0145","unstructured":"ICH Q1A(R2). International Conference on Harmonization (ICH). Guidance for industry: Q1A(R2) STABILITY TESTING OF NEW DRUG SUBSTANCES AND PRODUCTS. Ich Harmonised Tripartite Guideline. 2003;4(February):24."},{"key":"10.1016\/j.ejpb.2022.04.009_b0150","doi-asserted-by":"crossref","first-page":"120933","DOI":"10.1016\/j.ijpharm.2021.120933","article-title":"Quality by design (QbD) optimization of diazepam-loaded nanostructured lipid carriers (NLC) for nose-to-brain delivery: Toxicological effect of surface charge on human neuronal cells","volume":"607","author":"Costa","year":"2021","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.ejpb.2022.04.009_b0155","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1208\/s12249-010-9388-x","article-title":"Dual-drug delivery system based on in situ gel-forming nanosuspension of forskolin to enhance antiglaucoma efficacy","volume":"11","author":"Gupta","year":"2010","journal-title":"AAPS PharmSciTech."},{"issue":"2","key":"10.1016\/j.ejpb.2022.04.009_b0160","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.ejpb.2012.09.006","article-title":"Evaluation of the in vitro release and pharmacokinetics of parenteral injectable formulations for steroids","volume":"83","author":"Nippe","year":"2013","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2022.04.009_b0165","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.carbpol.2016.03.074","article-title":"Nanoparticle-mediated interplay of chitosan and melatonin for improved wound epithelialisation","volume":"146","author":"Bla\u017eevi\u0107","year":"2016","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.ejpb.2022.04.009_b0170","doi-asserted-by":"crossref","unstructured":"Goos P, Jones B. Optimal Design of Experiments. 1st ed. Wiley, editor. 2011.","DOI":"10.1002\/9781119974017"},{"key":"10.1016\/j.ejpb.2022.04.009_b0175","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1159\/000321044","article-title":"Nasal Drug Delivery in Humans","volume":"40","author":"Bitter","year":"2011","journal-title":"Curr. Probl. Dermatol."},{"key":"10.1016\/j.ejpb.2022.04.009_b0180","doi-asserted-by":"crossref","first-page":"100396","DOI":"10.1016\/j.mtchem.2020.100396","article-title":"The glucocorticoid derivative with the phthalimide group cationic nanocrystal for ophthalmic application: a design space development approach","volume":"19","author":"Peters","year":"2021","journal-title":"Mater. Today Chem."},{"key":"10.1016\/j.ejpb.2022.04.009_b0185","doi-asserted-by":"crossref","first-page":"110895","DOI":"10.1016\/j.msec.2020.110895","article-title":"Rifampicin nanocrystals: Towards an innovative approach to treat tuberculosis","volume":"112","author":"Melo","year":"2020","journal-title":"Mater. Sci. Eng., C"},{"key":"10.1016\/j.ejpb.2022.04.009_b0190","first-page":"119026","article-title":"119026","volume":"577","author":"Meruva","year":"2020","journal-title":"Available from:"},{"key":"10.1016\/j.ejpb.2022.04.009_b0195","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.jddst.2018.04.005","article-title":"Nanoparticle-loaded gels for topical delivery of nitrofurazone: Effect of particle size on skin permeation and retention","volume":"45","author":"Liu","year":"2018","journal-title":"J. Drug Delivery Sci. Technol."},{"issue":"October 2019","key":"10.1016\/j.ejpb.2022.04.009_b0200","doi-asserted-by":"crossref","first-page":"101486","DOI":"10.1016\/j.jddst.2019.101486","article-title":"Design space approach in the development of esculetin nanocrystals by a small-scale wet-bead milling process","volume":"55","author":"Zuo","year":"2020","journal-title":"J. Drug Deliv. Sci. Technol. [Internet]"},{"issue":"April","key":"10.1016\/j.ejpb.2022.04.009_b0205","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ijpharm.2019.04.016","article-title":"Preparation of in situ hydrogels loaded with azelaic acid nanocrystals and their dermal application performance study","volume":"563","author":"Tomi\u0107","year":"2019","journal-title":"Int. J. Pharm."},{"issue":"6","key":"10.1016\/j.ejpb.2022.04.009_b0210","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.addr.2010.12.007","article-title":"Nanosizing for oral and parenteral drug delivery: A perspective on formulating poorly-water soluble compounds using wet media milling technology","volume":"63","author":"Merisko-Liversidge","year":"2011","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2022.04.009_b0215","doi-asserted-by":"crossref","first-page":"120724","DOI":"10.1016\/j.ijpharm.2021.120724","article-title":"A comparison study of lipid and polymeric nanoparticles in the nasal delivery of meloxicam: Formulation, characterization, and in vitro evaluation","volume":"604","author":"Akel","year":"2021","journal-title":"Int. J. Pharm."},{"issue":"7","key":"10.1016\/j.ejpb.2022.04.009_b0220","doi-asserted-by":"crossref","first-page":"755","DOI":"10.7150\/thno.10804","article-title":"Coating solid lipid nanoparticles with hyaluronic acid enhances antitumor activity against melanoma stem-like cells","volume":"5","author":"Shen","year":"2015","journal-title":"Theranostics"},{"issue":"77","key":"10.1016\/j.ejpb.2022.04.009_b0225","doi-asserted-by":"crossref","first-page":"73083","DOI":"10.1039\/C6RA11260A","article-title":"Hyaluronic acid anchored paclitaxel nanocrystals improves chemotherapeutic efficacy and inhibits lung metastasis in tumor-bearing rat model","volume":"6","author":"Sharma","year":"2016","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejpb.2022.04.009_b0230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jddst.2017.09.012","article-title":"Nanosuspensions based gel as delivery system of nitrofurazone for enhanced dermal bioavailability","volume":"43","author":"Shen","year":"2018","journal-title":"J. Drug Delivery Sci. Technol."},{"issue":"1-2","key":"10.1016\/j.ejpb.2022.04.009_b0235","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ijpharm.2006.11.066","article-title":"Controlled drug delivery to the lung: Influence of hyaluronic acid solution conformation on its adsorption to hydrophobic drug particles","volume":"330","author":"Rouse","year":"2007","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2022.04.009_b0240","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.carbpol.2018.09.071","article-title":"Smart nanocarrier based on PEGylated hyaluronic acid for deacetyl mycoepoxydience: High stability with enhanced bioavailability and efficiency","volume":"203","author":"Zhao","year":"2019","journal-title":"Carbohydr. Polym."},{"issue":"6","key":"10.1016\/j.ejpb.2022.04.009_b0245","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.addr.2011.02.001","article-title":"Physical and chemical stability of drug nanoparticles","volume":"63","author":"Wu","year":"2011","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1-2","key":"10.1016\/j.ejpb.2022.04.009_b0250","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.ijpharm.2008.12.030","article-title":"Production and characterization of Hesperetin nanosuspensions for dermal delivery","volume":"371","author":"Mishra","year":"2009","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2022.04.009_b0255","doi-asserted-by":"crossref","unstructured":"Alshora DH, Ibrahim MA, Elzayat E, Almeanazel OT, Alanazi F. Rosuvastatin calcium nanoparticles: Improving bioavailability by formulation and stabilization codesign. PLoS ONE [Internet]. 2018;13(7):1\u201317. Available from: http:\/\/dx.doi.org\/10.1371\/journal.pone.0200218.","DOI":"10.1371\/journal.pone.0200218"},{"issue":"8","key":"10.1016\/j.ejpb.2022.04.009_b0260","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.jsps.2017.07.008","article-title":"Development, stability and in vitro delivery profile of new loratadine-loaded nanoparticles","volume":"25","author":"Rodriguez Amado","year":"2017","journal-title":"Saudi Pharm. J."},{"issue":"1","key":"10.1016\/j.ejpb.2022.04.009_b0265","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s40204-020-00148-x","article-title":"Preparation, optimization, and evaluation of midazolam nanosuspension: enhanced bioavailability for buccal administration","volume":"10","author":"Soroushnia","year":"2021","journal-title":"Prog. Biomater."},{"issue":"15","key":"10.1016\/j.ejpb.2022.04.009_b0270","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/molecules24152744","article-title":"Effect of surfactant concentrations on physicochemical properties and functionality of curcumin nanoemulsions under conditions relevant to commercial utilization","volume":"24","author":"Chuacharoen","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.ejpb.2022.04.009_b0275","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.foodhyd.2014.07.011","article-title":"Preparation and characterization of nanoemulsion encapsulating curcumin","volume":"43","author":"Sari","year":"2015","journal-title":"Food Hydrocolloids"},{"key":"10.1016\/j.ejpb.2022.04.009_b0280","unstructured":"T.G. Mezger, The Rheology Handbook For users of rotational and oscillatory rheometers. 2nd ed. Vincentz Network, Hanover, Germany; 2006."},{"issue":"1-2","key":"10.1016\/j.ejpb.2022.04.009_b0285","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ijpharm.2015.04.011","article-title":"Development of mucoadhesive sprayable gellan gum fluid gels","volume":"488","author":"Mahdi","year":"2015","journal-title":"Int. J. Pharm."},{"issue":"5","key":"10.1016\/j.ejpb.2022.04.009_b0290","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.ejps.2008.09.001","article-title":"Assessment of the influence factors on in vitro testing of nasal sprays using Box-Behnken experimental design","volume":"35","author":"Guo","year":"2008","journal-title":"Eur. J. Pharm. Sci."},{"issue":"6","key":"10.1016\/j.ejpb.2022.04.009_b0295","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/j.carres.2005.01.017","article-title":"A fluorescence study of sodium hyaluronate\/surfactant interactions in aqueous media","volume":"340","author":"Yin","year":"2005","journal-title":"Carbohydr. Res."},{"issue":"1","key":"10.1016\/j.ejpb.2022.04.009_b0300","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s11095-009-0002-4","article-title":"Assessment of nasal spray deposition pattern in a silicone human nose model using a color-based method","volume":"27","author":"Kundoor","year":"2010","journal-title":"Pharm. Res."},{"issue":"9","key":"10.1016\/j.ejpb.2022.04.009_b0305","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1080\/02786826.2014.931566","article-title":"A comparison of the deposition patterns of different nasal spray formulations using a nasal cast","volume":"48","author":"Pu","year":"2014","journal-title":"Aerosol Sci. Technol."},{"issue":"3","key":"10.1016\/j.ejpb.2022.04.009_b0310","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1007\/s13346-020-00800-w","article-title":"Piribedil loaded thermo-responsive nasal in situ gelling system for enhanced delivery to the brain: formulation optimization, physical characterization, and in vitro and in vivo evaluation","volume":"11","author":"Uppuluri","year":"2021","journal-title":"Drug Delivery and Translational Res."},{"key":"10.1016\/j.ejpb.2022.04.009_b0315","doi-asserted-by":"crossref","first-page":"69","DOI":"10.2174\/2211738506666180130105919","article-title":"Formulation and evaluation of niosomal in-situ nasal gel of Buspirone Hydrochloride for brain delivery","volume":"06","author":"Dua","year":"2018","journal-title":"Pharmaceutical Nanotechnol."},{"key":"10.1016\/j.ejpb.2022.04.009_b0320","unstructured":"European Medicines Agency. Committee for medicinal products for human use (CHMP): Guideline on the pharmaceutical quality of inhalation and nasal products. 2006. p. 27."},{"key":"10.1016\/j.ejpb.2022.04.009_b0325","unstructured":"US Food and Drug Administration. Guidance for Industry Nasal Spray and Inhalation Solution, Suspension, and Spray Drug Products \u2014 Chemistry, Manufacturing, and Controls Documentation \u2018 U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation an. Online [Internet]. 2002;(July):10\u20135. Available from: https:\/\/www.fda.gov\/media\/70857\/download."},{"issue":"4","key":"10.1016\/j.ejpb.2022.04.009_b0330","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1089\/jamp.2016.1328","article-title":"Elucidation of Formulation and Delivery Device-Related Effects on in Vitro Performance of Nasal Spray with Implication to Rational Product Specification Identification","volume":"30","author":"Grma\u0161","year":"2017","journal-title":"J. Aerosol Med. Pulmonary Drug Delivery"},{"issue":"4","key":"10.1016\/j.ejpb.2022.04.009_b0335","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1080\/10837450.2018.1514523","article-title":"Montelukast nasal spray: formulation development and in vitro evaluation","volume":"24","author":"Jullaphant","year":"2019","journal-title":"Pharm. Dev. Technol."},{"issue":"7","key":"10.1016\/j.ejpb.2022.04.009_b0340","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.3390\/antiox10071109","article-title":"Nasal spray formulations based on combined hyalurosomes and glycerosomes loading zingiber officinalis extract as green and natural strategy for the treatment of rhinitis and rhinosinusitis","volume":"10","author":"Casula","year":"2021","journal-title":"Antioxidants."},{"key":"10.1016\/j.ejpb.2022.04.009_b0345","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.ejpb.2014.12.015","article-title":"Predicting critical micelle concentration and micelle molecular weight of polysorbate 80 using compendial methods","volume":"94","author":"Braun","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"4","key":"10.1016\/j.ejpb.2022.04.009_b0350","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1208\/s12249-018-0993-4","article-title":"Multi-faceted Characterization of Wet-milled Griseofulvin Nanosuspensions for Elucidation of Aggregation State and Stabilization Mechanisms","volume":"19","author":"Li","year":"2018","journal-title":"AAPS PharmSciTech."},{"key":"10.1016\/j.ejpb.2022.04.009_b0355","doi-asserted-by":"crossref","first-page":"118911","DOI":"10.1016\/j.ijpharm.2019.118911","article-title":"Impact of physicochemical properties of nasal spray products on drug deposition and transport in the pediatric nasal cavity model","volume":"574","author":"Sosnowski","year":"2020","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.ejpb.2022.04.009_b0360","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13065-016-0176-x","article-title":"Surface tension examination of various liquid oral, nasal, and ophthalmic dosage forms","volume":"10","author":"Han","year":"2016","journal-title":"Chem. Cent. J."},{"issue":"4","key":"10.1016\/j.ejpb.2022.04.009_b0365","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1089\/jam.2007.0638","article-title":"The influence of spray properties on intranasal deposition","volume":"20","author":"Foo","year":"2007","journal-title":"J. Aerosol Med.: Deposition, Clearance, and Effects in the Lung"},{"key":"10.1016\/j.ejpb.2022.04.009_b0370","doi-asserted-by":"crossref","unstructured":"Cheng YS, Holmes TD, Gao J, Guilmette RA, Li S, Surakitbanharn Y, et al. Characterization of Nasal Spray Pumps and Deposition Pattern in a Replica of the Human Nasal Airway. Journal of Aerosol Medicine [Internet]. 2001;14(2):267\u201380. Available from: http:\/\/www.liebertonline.com\/doi\/abs\/10.1089\/08942680152484199.","DOI":"10.1089\/08942680152484199"},{"issue":"4","key":"10.1016\/j.ejpb.2022.04.009_b0375","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1021\/acs.molpharmaceut.7b00702","article-title":"Personalized Medicine in Nasal Delivery: The Use of Patient-Specific Administration Parameters to Improve Nasal Drug Targeting Using 3D-Printed Nasal Replica Casts","volume":"15","author":"Warnken","year":"2018","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejpb.2022.04.009_b0380","doi-asserted-by":"crossref","first-page":"119341","DOI":"10.1016\/j.ijpharm.2020.119341","article-title":"In vitro assessment of an idealized nose for nasal spray testing: Comparison with regional deposition in realistic nasal replicas","volume":"582","author":"Chen","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2022.04.009_b0385","doi-asserted-by":"crossref","unstructured":"P.G. Djupesland, R.A. Mahmoud, Role of nasal casts for in vitro evaluation of nasal drug delivery and quantitative evaluation of various nasal casts. 11 (2020) 485\u201395.","DOI":"10.4155\/tde-2020-0054"},{"issue":"9","key":"10.1016\/j.ejpb.2022.04.009_b0390","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1615\/AtomizSpr.v19.i9.10","article-title":"Assesment of parameters for distinguishing droplet shape in a spray field using image based techniques","volume":"19","author":"Ghaemi","year":"2009","journal-title":"Atom. Sprays"},{"issue":"18","key":"10.1016\/j.ejpb.2022.04.009_b0395","doi-asserted-by":"crossref","first-page":"6878","DOI":"10.3390\/ijms21186878","article-title":"Nasal polyposis: Insights in epithelial-mesenchymal transition and differentiation of polyp mesenchymal stem cells","volume":"21","author":"Chiarella","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejpb.2022.04.009_b0400","doi-asserted-by":"crossref","first-page":"120103","DOI":"10.1016\/j.ijpharm.2020.120103","article-title":"In vitro evaluation of regional nasal drug delivery using multiple anatomical nasal replicas of adult human subjects and two nasal sprays","volume":"593","author":"Manniello","year":"2021","journal-title":"Int. J. Pharm."},{"issue":"5","key":"10.1016\/j.ejpb.2022.04.009_b0405","first-page":"1","article-title":"New ethanol and propylene glycol free gel formulations containing a minoxidil-methyl- b -cyclodextrin complex as promising tools for alopecia treatment","volume":"41","author":"Lopedota","year":"2014","journal-title":"Drug Dev. Ind. Pharm."},{"issue":"10","key":"10.1016\/j.ejpb.2022.04.009_b0410","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1111\/j.1365-2222.2009.03306.x","article-title":"Dissolution in nasal fluid, retention and anti-inflammatory activity of fluticasone furoate in human nasal tissue ex vivo","volume":"39","author":"Baumann","year":"2009","journal-title":"Clin. Exp. Allergy"},{"key":"10.1016\/j.ejpb.2022.04.009_b0415","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jddst.2015.02.002","article-title":"An inclusion complex of fluticasone propionate with \u03b3-cyclodextrin in aqueous solution and in a solid state","volume":"26","author":"Tokumura","year":"2015","journal-title":"J. Drug Delivery Sci. Technol."},{"issue":"1-2","key":"10.1016\/j.ejpb.2022.04.009_b0420","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ijpharm.2017.02.030","article-title":"In situ determination of the saturation solubility of nanocrystals of poorly soluble drugs for dermal application","volume":"521","author":"Colombo","year":"2017","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.ejpb.2022.04.009_b0425","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ijpharm.2011.08.026","article-title":"Lutein nanocrystals as antioxidant formulation for oral and dermal delivery","volume":"420","author":"Mitri","year":"2011","journal-title":"Int. J. Pharm."},{"issue":"3","key":"10.1016\/j.ejpb.2022.04.009_b0430","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1208\/s12249-021-01963-6","article-title":"Development of Nanonized Nitrendipine and Its Transformation into Nanoparticulate Oral Fast Dissolving Drug Delivery System","volume":"22","author":"Gandhi","year":"2021","journal-title":"AAPS PharmSciTech."},{"issue":"6","key":"10.1016\/j.ejpb.2022.04.009_b0435","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1007\/s11095-021-03056-2","article-title":"Surfactant-Free Glibenclamide Nanoparticles: Formulation, Characterization and Evaluation of Interactions with Biological Barriers","volume":"38","author":"Arrua","year":"2021","journal-title":"Pharm. Res."},{"issue":"1","key":"10.1016\/j.ejpb.2022.04.009_b0440","doi-asserted-by":"crossref","DOI":"10.1208\/s12249-021-02164-x","article-title":"Fabrication of Stable Apigenin Nanosuspension with PEG 400 as Antisolvent for Enhancing the Solubility and Bioavailability","volume":"23","author":"Xu","year":"2022","journal-title":"AAPS PharmSciTech."},{"issue":"11","key":"10.1016\/j.ejpb.2022.04.009_b0445","doi-asserted-by":"crossref","first-page":"4869","DOI":"10.1002\/jps.21380","article-title":"Fluticasone and Budesonide Nanosuspensions for Pulmonary Delivery: Preparation, Characterization, and Pharmacokinetic Studies","volume":"97","author":"Yang","year":"2008","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2022.04.009_b0450","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.msec.2017.03.002","article-title":"Quality by Design approach for an in situ gelling microemulsion of Lorazepam via intranasal route","volume":"75","author":"Shah","year":"2017","journal-title":"Mater. Sci. Eng., C"},{"issue":"8","key":"10.1016\/j.ejpb.2022.04.009_b0455","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.3390\/polym12081800","article-title":"Hyaluronic acid: The influence of molecular weight on structural, physical, physico-chemical, and degradable properties of biopolymer","volume":"12","author":"Snetkov","year":"2020","journal-title":"Polymers."},{"issue":"1","key":"10.1016\/j.ejpb.2022.04.009_b0460","first-page":"75","article-title":"Nasal delivery of fentanyl. Drug Delivery and Translational","volume":"3","author":"Watts","year":"2013","journal-title":"Research."},{"key":"10.1016\/j.ejpb.2022.04.009_b0465","unstructured":"PecFent SmPC. PecFent [Internet]. European Medicines Agency. [cited 2021 Dec 1]. Available from: www.ema.europa.ea."},{"key":"10.1016\/j.ejpb.2022.04.009_b0470","unstructured":"SmPC. Hysan [Internet]. [cited 2021 Dec 1]. Available from: https:\/\/hysan.prohealth.com.mt\/."},{"key":"10.1016\/j.ejpb.2022.04.009_b0475","unstructured":"Sterimar [Internet]. [cited 2021 Dec 1]. Available from: https:\/\/www.sterimarnasal.co.uk\/."},{"issue":"7","key":"10.1016\/j.ejpb.2022.04.009_b0480","doi-asserted-by":"crossref","first-page":"969","DOI":"10.3390\/pharmaceutics13070969","article-title":"Development of a cyclodextrin-based mucoadhesive-thermo-sensitive in situ gel for clonazepam intranasal delivery","volume":"13","author":"Cirri","year":"2021","journal-title":"Pharmaceutics"},{"issue":"10","key":"10.1016\/j.ejpb.2022.04.009_b0485","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1002\/alr.21193","article-title":"Intranasal sodium hyaluronate on the nasal cytology of patients with allergic and nonallergic rhinitis","volume":"3","author":"Gelardi","year":"2013","journal-title":"Int. Forum Allergy Rhinol."},{"issue":"5","key":"10.1016\/j.ejpb.2022.04.009_b0490","doi-asserted-by":"crossref","first-page":"340","DOI":"10.2500\/ajra.2016.30.4344","article-title":"Effect of sodium hyaluronate added to topical corticosteroids in chronic rhinosinusitis with nasal polyposis","volume":"30","author":"Cantone","year":"2016","journal-title":"Am. J. Rhinol. Allergy"},{"issue":"6","key":"10.1016\/j.ejpb.2022.04.009_b0495","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1177\/1945892420923927","article-title":"Evaluation of Performance and Tolerability of Nebulized Hyaluronic Acid Nasal Hypertonic Solution in the Treatment of Chronic Rhinosinusitis","volume":"34","author":"Monzani","year":"2020","journal-title":"Am. J. Rhinol. Allergy"},{"issue":"4","key":"10.1016\/j.ejpb.2022.04.009_b0500","doi-asserted-by":"crossref","first-page":"102502","DOI":"10.1016\/j.amjoto.2020.102502","article-title":"Effectiveness of micronized nasal irrigations with hyaluronic acid\/isotonic saline solution in non-polipoid chronic rhinosinusitis: a prospective, randomized, double-blind, controlled study","volume":"41","author":"Savietto","year":"2020","journal-title":"Am. J. Otolaryngol."},{"key":"10.1016\/j.ejpb.2022.04.009_b0505","unstructured":"Flixonase [Internet]. [cited 2021 Dec 1]. Available from: https:\/\/www.medicines.org.uk\/emc\/product\/5503\/smpc#gref."},{"key":"10.1016\/j.ejpb.2022.04.009_b0510","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ijpharm.2019.02.026","article-title":"How to characterize a nasal product. The state of the art of in vitro and ex vivo specific methods","volume":"561","author":"Salade","year":"2019","journal-title":"Int. J. Pharmaceutics. Elsevier B.V."},{"issue":"10","key":"10.1016\/j.ejpb.2022.04.009_b0515","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1080\/17425247.2018.1517741","article-title":"In situ gelling and mucoadhesive polymers: why do they need each other?","volume":"15","author":"Zahir-Jouzdani","year":"2018","journal-title":"Expert Opin. Drug Deliv."},{"issue":"3","key":"10.1016\/j.ejpb.2022.04.009_b0520","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1080\/10837450802498910","article-title":"Formulation and evaluation of in situ gelling system of dimenhydrinate for nasal administration","volume":"14","author":"Belgamwar","year":"2009","journal-title":"Pharm. Dev. Technol."},{"issue":"3","key":"10.1016\/j.ejpb.2022.04.009_b0525","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.ejpb.2014.08.015","article-title":"Preparation and in vitro characterization of thermosensitive and mucoadhesive hydrogels for nasal delivery of phenylephrine hydrochloride","volume":"88","author":"Xu","year":"2014","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"3","key":"10.1016\/j.ejpb.2022.04.009_b0530","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0173902","article-title":"Histological and anatomical structure of the nasal cavity of Bama minipigs","volume":"12","author":"Yang","year":"2017","journal-title":"PLoS ONE"},{"issue":"8","key":"10.1016\/j.ejpb.2022.04.009_b0535","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics11080367","article-title":"Improved in vitro model for intranasal mucosal drug delivery: Primary olfactory and respiratory epithelial cells compared with the permanent Nasal cell line RPMI 2650","volume":"11","author":"Ladel","year":"2019","journal-title":"Pharmaceutics"},{"issue":"1\u20132","key":"10.1016\/j.ejpb.2022.04.009_b0540","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ijpharm.2011.04.001","article-title":"New insights into the mucoadhesion of pectins by AFM roughness parameters in combination with SPR","volume":"411","author":"Joergensen","year":"2011","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.ejpb.2022.04.009_b0545","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/gels4010019","article-title":"Weak and strong gels and the emergence of the amorphous solid state","volume":"4","author":"Douglas","year":"2018","journal-title":"Gels"}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641122000819?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641122000819?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T16:46:35Z","timestamp":1760546795000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641122000819"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":109,"alternative-id":["S0939641122000819"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2022.04.009","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In situ gelling nanosuspension as an advanced platform for fluticasone propionate nasal delivery","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2022.04.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}